Sinora

Sinora (Noradrenaline Tartrate) is an intravenous medication used to treat severe low blood pressure. It helps restore blood flow to vital organs during critical care. This vasopressor supports circulation in emergency and surgical settings. Suitable for patients requiring immediate hemodynamic stabilization.

Noradrenaline Tartrate is primarily used to raise blood pressure in adults experiencing acute hypotension. It is administered in emergency care, intensive care units, and during surgical procedures when blood pressure drops dangerously low. The medication helps maintain adequate blood flow to the heart, brain, and other organs. It is not a first-line treatment for mild or chronic low blood pressure.

Noradrenaline Tartrate works by constricting blood vessels, which increases vascular resistance and raises blood pressure. Patients may experience improved circulation and organ perfusion shortly after administration. The effects are typically noticeable within minutes of intravenous infusion. Overuse or improper dosing may lead to reduced blood flow to extremities.

This medication should only be handled and administered by trained healthcare professionals. It requires careful monitoring of blood pressure, heart rate, and urine output during use. Patients with certain heart conditions or blood vessel disorders may need adjusted dosing. Always inform medical staff of any pre-existing conditions before administration.

Noradrenaline Tartrate may interact with medications that affect heart rhythm or blood pressure, including beta-blockers and certain antidepressants. Combining it with alcohol or sedatives can increase the risk of side effects. Patients using MAO inhibitors or tricyclic antidepressants should use this medication with caution. Always disclose all current medications to healthcare providers.